U.S., Dec. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07294898) titled 'A Study to Investigate the Effect of a Low-fat Meal and Evening Dosing on KAI-7535 in Participants Living With Obesity or Overweight' on Dec. 08.

Brief Summary: The primary objective of this study is to evaluate the effect of a meal and evening dosing on the pharmacokinetics (PK) of KAI 7535 in healthy participants living with obesity or overweight.

Study Start Date: Dec. 11

Study Type: INTERVENTIONAL

Condition: Obesity Overweight

Intervention: DRUG: KAI-7535

Oral tablets.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Kailera

Published by HT Digital Content Services with permission from Health Daily Digest....